Drug Safety Associate at Enterprise
High Conscientiousness and Emotional Stability to process ICSRs, meet expedited reporting deadlines, and maintain the pharmacovigilance database.
In enterprise pharma, multi-market regulatory complexity is the norm
10-15 year development cycles require genuine long-term vision
Pharmacovigilance and patient safety are non-delegable responsibilities
Ideal OCEAN+ Profile
At enterprise companies (201-1000 employees), ability to interpret complex cases, identify emerging signals, and adapt processes to new ICH E2 guidelines and local regulations
At enterprise companies (201-1000 employees), precision in documenting adverse events, meeting expedited deadlines (7/15 days), and maintaining the pharmacovigilance database
At enterprise companies (201-1000 employees), communication with physicians and reporters to obtain additional case information; internal presentations of safety metrics
At enterprise companies (201-1000 employees), collaboration with medical, regulatory, and legal teams to evaluate and manage complex safety cases
At enterprise companies (201-1000 employees), tolerance for peak case volumes, pressure from regulatory deadlines, and the distressing nature of serious adverse event report content
At enterprise companies (201-1000 employees), the pharmacovigilance associate operates under regulatory reporting deadlines for adverse events (15 days for SUSARs, 7 days for fatal cases) and defined case-handling processes; adherence to case processing pace is non-negotiable
Strengths and Red Flags
Strengths
- Accurate, on-time processing of ICSRs within expedited regulatory deadlines
- Maintaining the quality and consistency of the safety database
- Managing product portfolios across multiple development and commercialization phases
- Robust regulatory compliance with FDA, EMA, and local health authorities
Red Flags
- Case processing errors that cause expedited reports to miss deadlines
- Inconsistent MedDRA term coding that compromises signal detection
- Paralysis in the face of complex multi-product, multi-phase portfolios
- Internal bureaucracy that delays go/no-go pipeline decisions
Interview Questions
How many cases do you process on average per month? What is your expedited deadline compliance rate, and how do you handle volume spikes?
Evaluates: Conscientiousness and management of high-precision operational workload
Describe your process for coding MedDRA terms on a case with multiple adverse events. What criteria do you use to select the most appropriate term?
Evaluates: Conscientiousness and technical rigor in safety processing
How did you manage a multi-product portfolio across different development phases?
Evaluates: Systemic vision and prioritization capacity at scale
How did you coordinate a multi-market regulatory registration process?
Evaluates: Conscientiousness and coordination in highly complex environments
More about Drug Safety Associate
Career path, personality archetypes and similar roles in the full profile.
This Role in Other Contexts
Drug Safety Associate — base profile with no company context
View profile → Startup (1-50 employees)In pharma startups, time to regulatory approval defines survival
View profile → SMB (51-200 employees)In SMB pharma, quality and compliance are the license to operate
View profile → Global (1001+ employees)Global pharma means registrations in dozens of markets with different requirements
View profile →You're hiring a Drug Safety Associate at Enterprise (201-1000 employees). Is your company ready?
This profile describes who to look for. The Talent Diagnostic measures the other half: how ready your organization is for that person to perform. Free, no signup.
20 statements · 5 min · no card